JCRS Highlights - selected by Thomas Kohnen, European Editor, JCRS

Vol: 45 Issue: 10 Month: October 2019

JCRS Highlights - selected by Thomas Kohnen, European Editor, JCRS
Thomas Kohnen
Thomas Kohnen
Published: Friday, November 29, 2019
Bag-in-the-lens calculation in paediatric patients Cataract surgery in paediatric patients presents many challenges, not least of which is calculating the correct IOL power for a growing eye. While the bag-in-the-lens (BIL) technique has been shown to significantly reduce postoperative PCO rates in these patients, little is known about predicting postoperative outcomes. A new consecutive case series study looked at the precision of BIL IOL power calculation in 87 eyes of 56 patients who were divided into four groups based on age. The researchers calculated IOL power using the SRK/T formula. The mean prediction error (PE) for the entire group was 1.79 dioptres. This ranged from 3.43D in the youngest patients (0-3 months) to 1.33 in the oldest patients (3-17 years). The PE after IOL implantation correlated inversely with age group and axial length, but not with corneal radii and corneal astigmatism. LM Lytvynchuk et al., JCRS, “Precision of bag-in-the-lens intraocular lens power calculation in different age groups of paediatric cataract patients: Report of the Giessen Pediatric Cataract Study Group”, Vol. 45, #10, 1372-79. PCO in paediatric cataract Posterior capsule opacification (PCO) is the most common complication of paediatric cataract surgery. Does the IOL type make a difference? A case series study compared outcomes in 103 eyes of 80 children who received either a hydrophilic IOL (Ocular ANU6 IOL) or a hydrophobic IOL (AcrySof SA60AT) and were followed for more than three years. When the posterior capsule was left intact, 39.3% of eyes in the hydrophilic group and 13.4% of eyes in the hydrophobic group developed PCO. When primary posterior capsulotomy and anterior vitrectomy were performed, 4.3% and 6.8%, respectively, developed PCO. Follow-up analysis showed a survival (i.e., no PCO formation at five-year follow-up) rate of 95.4% in the hydrophobic group and 88.8% in the hydrophilic group. P Sen et al., JCRS, “Posterior capsule opacification rate after https://www.eurotimes.org/wp-admin/post-new.php#category-addphacoemulsification in pediatric cataract: Hydrophilic versus hydrophobic intraocular lenses”, Vol. 45, #10, 1380-85. Blue versus violet filter IOL comparison Violet light-filtering IOLs were developed to reduce exposure to the violet wavelength (400-to-440nm). Although these IOLs have been available for some time, clinical outcomes have not been reported. Japanese researchers conducted a prospective study of 55 patients with bilateral cataract who were randomly allocated to a blue light-filtering IOL (AcrySof IQ SN60WF) in one eye and to a violet light-filtering IOL (OptiBlue ZCB00V) in the fellow eye. Postoperative contrast sensitivity under photopic condition at one week and three months and contrast sensitivity under mesopic conditions at three months were significantly better with the violet light-filtering IOL than with the blue light-filtering IOL. S Nakano et al., JCRS, “Blue light–filtering and violet light–filtering hydrophobic acrylic foldable intraocular lenses: Intraindividual comparison”, Vol. 45, #10, 1393-97.
Tags: cataract and refractive
Latest Articles
ESCRS Today 2025: Happy Anniversaries!

ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.

Read more...

ESCRS Today 2025: A Congress for Everyone

From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.

Read more...

ESCRS Today 2025: All Eyes on Innovation

Watching out for obstacles and opportunities

Read more...

Beyond the Numbers

Empowering patient participation fosters continuous innovation in cataract surgery.

Read more...

Thinking Beyond the Surgery Room

Practice management workshop focuses on financial operations and AI business applications.

Read more...

Aid Cuts Threaten Global Eye Care Progress

USAID closure leads retreat in development assistance.

Read more...

Supplement: ESCRS Clinical Trends Series: Presbyopia

Read more...

Debate: FS-LASIK or KLEx for Hyperopia?

FS-LASIK has more of a track record, but KLEx offers advantages.

Read more...

Four AI Applications Ready for Practice

Commercial offerings may save time, improve practice and research.

Read more...

Perioperative Medication Regimens for Cataract Surgery

Randomised controlled clinical trial results provide evidence-based guidance.

Read more...